Perfusate adsorption during ex vivo lung perfusion improves early post-transplant lung function
- PMID: 32201002
- DOI: 10.1016/j.jtcvs.2019.12.128
Perfusate adsorption during ex vivo lung perfusion improves early post-transplant lung function
Abstract
Objective: Improvement in ex vivo lung perfusion protocols could increase the number of donors available for transplantation and protect the lungs from primary graft dysfunction. We hypothesize that perfusate adsorption during ex vivo lung perfusion reconditions the allograft to ischemia-reperfusion injury after lung transplantation.
Methods: Donor pig lungs were preserved for 24 hours at 4°C, followed by 6 hours of ex vivo lung perfusion according to the Toronto protocol. The perfusate was additionally adsorbed through a CytoSorb adsorber (CytoSorbents, Berlin, Germany) in the treatment group, whereas control lungs were perfused according to the standard protocol (n = 5, each). Ex vivo lung perfusion physiology and biochemistry were monitored. Upon completion of ex vivo lung perfusion, a left single lung transplantation was performed. Oxygenation function and lung mechanics were assessed during a 4-hour reperfusion period. The inflammatory response was determined during ex vivo lung perfusion and reperfusion.
Results: The cytokine concentrations in the perfusate were markedly lower with the adsorber, resulting in improved ex vivo lung perfusion physiology and biochemistry during the 6-hour perfusion period. Post-transplant dynamic lung compliance was markedly better during the 4-hour reperfusion period in the treatment group. Isolated allograft oxygenation function and dynamic compliance continued to be superior in the adsorber group at the end of reperfusion, accompanied by a markedly decreased local inflammatory response.
Conclusions: Implementation of an additional cytokine adsorber has refined the standard ex vivo lung perfusion protocol. Furthermore, cytokine removal during ex vivo lung perfusion improved immediate post-transplant graft function together with a less intense inflammatory response to reperfusion in pigs. Further studies are warranted to understand the beneficial effects of perfusate adsorption during ex vivo lung perfusion in the clinical setting.
Keywords: cytosorb; ex vivo lung perfusion; inflammatory response; ischemia-reperfusion injury; lung transplantation; perfusate adsoprtion.
Copyright © 2020 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
Comment in
-
Commentary: Ex vivo lung perfusion plus solute adsorption: An exorcism of evil humors?J Thorac Cardiovasc Surg. 2021 Feb;161(2):e123-e124. doi: 10.1016/j.jtcvs.2019.12.009. Epub 2019 Dec 21. J Thorac Cardiovasc Surg. 2021. PMID: 31959434 No abstract available.
-
Commentary: 'Tis the season to filter your perfusate.J Thorac Cardiovasc Surg. 2021 Feb;161(2):e127-e128. doi: 10.1016/j.jtcvs.2019.12.012. Epub 2019 Dec 20. J Thorac Cardiovasc Surg. 2021. PMID: 31959447 No abstract available.
-
Commentary: Double, double, toil, and trouble: Removing evil humours during ex vivo lung perfusion.J Thorac Cardiovasc Surg. 2021 Feb;161(2):e125-e126. doi: 10.1016/j.jtcvs.2019.12.011. Epub 2019 Dec 20. J Thorac Cardiovasc Surg. 2021. PMID: 31959451 No abstract available.
-
Commentary: Ischemia reperfusion-Looking ahead.J Thorac Cardiovasc Surg. 2021 Feb;161(2):e124-e125. doi: 10.1016/j.jtcvs.2019.12.010. Epub 2019 Dec 20. J Thorac Cardiovasc Surg. 2021. PMID: 32107028 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
